Chouinard Michel 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Dec 27, 2010
Insider Transaction Report
Form 4
Chouinard Michel
COO, Biovail Labs.Int'l SRL
Transactions
- Award
Restricted Share Units
2010-12-22+157→ 4,837 totalFrom: 2012-02-25Exp: 2012-02-25→ Common Stock, no par value (157 underlying) - Award
Restricted Share Units
2010-12-22+148→ 4,584 totalFrom: 2013-02-17Exp: 2013-02-17→ Common Stock, no par value (148 underlying) - Award
Restricted Share Units
2010-12-22+128→ 3,946 totalFrom: 2011-03-12Exp: 2011-03-12→ Common Stock, no par value (128 underlying)
Footnotes (2)
- [F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one share of Common Stock, no par value, of Valeant Pharmaceuticals International, Inc. (the "Common Stock").
- [F2]Represents dividend equivalents accrued on RSUs as a result of a dividend paid on the Common Stock on December 22, 2010.